Lynda Bourebaba
- Equine top 5%
- Veterinary Equine Medical Research 3
-
- Hormonal and reproductive studies 4
- Natural Antidiabetic Agents Studies 4
- Food Science top 10%
-
- Adipose Tissue and Metabolism 7
-
- Liver Disease Diagnosis and Treatment 5
-
- Mesenchymal stem cell research 4
-
- MicroRNA in disease regulation 3
-
- Lipid metabolism and disorders 3
- Co-authors
- Krzysztof MaryczMalwina MularczykMichael RöckenKatarzyna Kornicka‐GarbowskaFatiha BedjouIzabela MichalakJacek ŁyczkoAgnieszka Śmieszek
- Journals
- PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)Stem Cells (1 paper)
- Partner nations
- PolandUnited StatesAlgeria
In The Last Decade
Lynda Bourebaba
33 papers receiving 568 citations
Peers
Comparison fields: 5 of 101
- Equine 21
- Drug Discovery 1
- Endocrinology, Diabetes and Metabolism 84
- Biochemistry 27
- Food Science 72
Countries citing papers authored by Lynda Bourebaba
This map shows the geographic impact of Lynda Bourebaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Bourebaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Bourebaba more than expected).
Fields of papers citing papers by Lynda Bourebaba
This network shows the impact of papers produced by Lynda Bourebaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Bourebaba. The network helps show where Lynda Bourebaba may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Lynda Bourebaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 38 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 23 | |
| 17 | 2019 | 27 | |
| 18 | 2019 | 19 | |
| 19 | 2019 | 16 | |
| 20 | 2016 | 23 |
About Lynda Bourebaba
Lynda Bourebaba is a scholar working on Equine, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 35 papers that have together received 581 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Hormonal and reproductive studies (4 papers), Natural Antidiabetic Agents Studies (4 papers), Mesenchymal stem cell research (4 papers), MicroRNA in disease regulation (3 papers), Lipid metabolism and disorders (3 papers) and Veterinary Equine Medical Research (3 papers). The work is most often cited by research in Equine (21 citations), Drug Discovery (1 citation) and Endocrinology, Diabetes and Metabolism (84 citations). Lynda Bourebaba has collaborated with scholars based in Poland, United States and Algeria. Frequent co-authors include Krzysztof Marycz, Malwina Mularczyk, Michael Röcken, Katarzyna Kornicka‐Garbowska, Fatiha Bedjou, Izabela Michalak, Jacek Łyczko, Agnieszka Śmieszek, Andrzej Fal and Bienvenida Gilbert‐López. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.